title: New molecular mechanism for Ullrich congenital muscular dystrophy: a heterozygous in-frame deletion in the COL6A1 gene causes a severe phenotype.
abstract: Recessive mutations in two of the three collagen VI genes, COL6A2 and COL6A3, have recently been shown to cause Ullrich congenital muscular dystrophy (UCMD), a frequently severe disorder characterized by congenital muscle weakness with joint contractures and coexisting distal joint hyperlaxity. Dominant mutations in all three collagen VI genes had previously been associated with the considerably milder Bethlem myopathy. Here we report that a de novo heterozygous deletion of the COL6A1 gene can also result in a severe phenotype of classical UCMD precluding ambulation. The internal gene deletion occurs near a minisatellite DNA sequence in intron 8 that removes 1.1 kb of genomic DNA encompassing exons 9 and 10. The resulting mutant chain contains a 33-amino acid deletion near the amino-terminus of the triple-helical domain but preserves a unique cysteine in the triple-helical domain important for dimer formation prior to secretion. Thus, dimer formation and secretion of abnormal tetramers can occur and exert a strong dominant negative effect on microfibrillar assembly, leading to a loss of normal localization of collagen VI in the basement membrane surrounding muscle fibers. Consistent with this mechanism was our analysis of a patient with a much milder phenotype, in whom we identified a previously described Bethlem myopathy heterozygous in-frame deletion of 18 amino acids somewhat downstream in the triple-helical domain, a result of exon 14 skipping in the COL6A1 gene. This deletion removes the crucial cysteine, so that dimer formation cannot occur and the abnormal molecule is not secreted, preventing the strong dominant negative effect. Our studies provide a biochemical insight into genotype-phenotype correlations in this group of disorders and establish that UCMD can be caused by dominantly acting mutations.
authors.affiliation: Department of Dermatology and Cutaneous Biology, Jefferson Institute of Molecular Medicine, Thomas Jefferson University, Philadelphia, PA 19107, USA.
authors.forename: Te-Cheng
authors.initials: TC
authors.lastname: Pan
authors.forename: Rui-Zhu
authors.initials: RZ
authors.lastname: Zhang
authors.forename: Dominick G
authors.initials: DG
authors.lastname: Sudano
authors.forename: Suely K
authors.initials: SK
authors.lastname: Marie
authors.forename: Carsten G
authors.initials: CG
authors.lastname: Bönnemann
authors.forename: Mon-Li
authors.initials: ML
authors.lastname: Chu
mesh_terms: D000595:Amino Acid Sequence; D001483:Base Sequence; D002648:Child; D024142:Collagen Type VI / Q000737:chemistry / Q000235:genetics*; D018076:DNA, Complementary / Q000235:genetics; D019281:Dimerization; D005091:Exons; D005109:Extracellular Matrix / Q000737:chemistry; D005347:Fibroblasts / Q000737:chemistry; D005799:Genes, Dominant; D005838:Genotype; D006579:Heterozygote; D006801:Humans; D007438:Introns; D008297:Male; D008969:Molecular Sequence Data; D009132:Muscles / Q000378:metabolism / Q000473:pathology; D009136:Muscular Dystrophies / Q000151:congenital* / Q000235:genetics* / Q000473:pathology; D010641:Phenotype; D017434:Protein Structure, Tertiary; D012333:RNA, Messenger / Q000235:genetics; D017384:Sequence Deletion; D012689:Sequence Homology, Nucleic Acid
chemical_list: D024142:Collagen Type VI; D018076:DNA, Complementary; D012333:RNA, Messenger